Annual Accounts Payable
$7.84 M
+$4.87 M+163.60%
December 31, 2023
Summary
- As of February 8, 2025, PMN annual accounts payable is $7.84 million, with the most recent change of +$4.87 million (+163.60%) on December 31, 2023.
- During the last 3 years, PMN annual accounts payable has risen by +$7.41 million (+1692.71%).
- PMN annual accounts payable is now at all-time high.
Performance
PMN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.58 M
-$440.00 K-21.83%
September 30, 2024
Summary
- As of February 8, 2025, PMN quarterly accounts payable is $1.58 million, with the most recent change of -$440.00 thousand (-21.83%) on September 30, 2024.
- Over the past year, PMN quarterly accounts payable has dropped by -$6.84 million (-81.28%).
- PMN quarterly accounts payable is now -81.28% below its all-time high of $8.41 million, reached on September 30, 2023.
Performance
PMN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PMN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +163.6% | -81.3% |
| 3 y3 years | +1692.7% | -12.2% |
| 5 y5 years | +1399.6% | +551.5% |
PMN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1817.6% | -81.3% | +285.1% |
| 5 y | 5-year | at high | +2103.1% | -81.3% | +575.2% |
| alltime | all time | at high | +3679.8% | -81.3% | >+9999.0% |
ProMIS Neurosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.58 M(-21.8%) |
| Jun 2024 | - | $2.02 M(+43.6%) |
| Mar 2024 | - | $1.40 M(-82.1%) |
| Dec 2023 | $7.84 M(+163.6%) | $7.84 M(-6.8%) |
| Sep 2023 | - | $8.41 M(+5.7%) |
| Jun 2023 | - | $7.96 M(+14.0%) |
| Mar 2023 | - | $6.99 M(+134.8%) |
| Dec 2022 | $2.98 M(+627.5%) | $2.98 M(+65.8%) |
| Sep 2022 | - | $1.79 M(+102.1%) |
| Jun 2022 | - | $888.00 K(+37.7%) |
| Mar 2022 | - | $644.80 K(+57.7%) |
| Dec 2021 | $409.00 K(-6.5%) | $409.00 K(-9.9%) |
| Sep 2021 | - | $453.70 K(+94.5%) |
| Jun 2021 | - | $233.30 K(-3.5%) |
| Mar 2021 | - | $241.80 K(-44.7%) |
| Dec 2020 | $437.50 K(+22.9%) | $437.50 K(-10.3%) |
| Sep 2020 | - | $487.80 K(-62.8%) |
| Jun 2020 | - | $1.31 M(+19.5%) |
| Mar 2020 | - | $1.10 M(+208.3%) |
| Dec 2019 | $356.00 K(-31.9%) | - |
| Dec 2019 | - | $356.00 K(-66.1%) |
| Sep 2019 | - | $1.05 M(+103.4%) |
| Jun 2019 | - | $516.90 K(+71.1%) |
| Mar 2019 | - | $302.10 K(-42.2%) |
| Dec 2018 | $523.00 K(+152.0%) | - |
| Dec 2018 | - | $523.00 K(+126.9%) |
| Sep 2018 | - | $230.50 K(-0.6%) |
| Jun 2018 | - | $231.80 K(+112.5%) |
| Mar 2018 | - | $109.10 K(-47.4%) |
| Dec 2017 | $207.50 K(-56.6%) | $207.50 K(-71.8%) |
| Sep 2017 | - | $734.60 K(+8.9%) |
| Jun 2017 | - | $674.30 K(+83.6%) |
| Mar 2017 | - | $367.30 K(-23.2%) |
| Dec 2016 | $478.10 K | $478.10 K(+16.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $412.30 K(+29.9%) |
| Jun 2016 | - | $317.30 K(-11.5%) |
| Mar 2016 | - | $358.40 K(+15.0%) |
| Dec 2015 | $311.70 K(-26.6%) | $311.70 K(+3.3%) |
| Sep 2015 | - | $301.70 K(-62.9%) |
| Jun 2015 | - | $812.30 K(+35.1%) |
| Mar 2015 | - | $601.30 K(+75.1%) |
| Dec 2014 | $424.50 K(-0.7%) | - |
| Sep 2014 | - | $343.50 K(+78.6%) |
| Jun 2014 | - | $192.30 K(-55.0%) |
| Mar 2014 | $427.40 K(-19.2%) | $427.40 K(-49.5%) |
| Dec 2013 | - | $845.50 K(+23.1%) |
| Sep 2013 | - | $687.10 K(+51.5%) |
| Jun 2013 | - | $453.60 K(-14.2%) |
| Mar 2013 | $528.80 K(+8.8%) | $528.80 K(+111.3%) |
| Dec 2012 | - | $250.30 K(-48.5%) |
| Mar 2012 | $486.00 K(-15.5%) | $486.00 K(-18.5%) |
| Dec 2008 | - | $596.10 K(-16.7%) |
| Sep 2008 | - | $715.90 K(-25.4%) |
| Jun 2008 | - | $960.20 K(+8.3%) |
| Dec 2007 | - | $886.70 K(+37.4%) |
| Sep 2007 | - | $645.30 K(+14.4%) |
| Jun 2007 | - | $563.90 K(-1.9%) |
| Mar 2007 | $575.10 K(+170.5%) | $575.10 K(+112.4%) |
| Dec 2006 | - | $270.70 K(+128.6%) |
| Sep 2006 | - | $118.40 K(-38.0%) |
| Jun 2006 | - | $191.00 K(-10.2%) |
| Mar 2006 | $212.60 K | $212.60 K(+24.5%) |
| Dec 2005 | - | $170.80 K(-32.4%) |
| Sep 2005 | - | $252.70 K(+84.7%) |
| Jun 2005 | - | $136.80 K(+623.8%) |
| Dec 2002 | - | $18.90 K(-80.6%) |
| Dec 2001 | - | $97.40 K(-40.0%) |
| Dec 2000 | - | $162.20 K(+3144.0%) |
| Jun 2000 | - | $5000.00 |
FAQ
- What is ProMIS Neurosciences annual accounts payable?
- What is the all time high annual accounts payable for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual accounts payable year-on-year change?
- What is ProMIS Neurosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly accounts payable year-on-year change?
What is ProMIS Neurosciences annual accounts payable?
The current annual accounts payable of PMN is $7.84 M
What is the all time high annual accounts payable for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual accounts payable is $7.84 M
What is ProMIS Neurosciences annual accounts payable year-on-year change?
Over the past year, PMN annual accounts payable has changed by +$4.87 M (+163.60%)
What is ProMIS Neurosciences quarterly accounts payable?
The current quarterly accounts payable of PMN is $1.58 M
What is the all time high quarterly accounts payable for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly accounts payable is $8.41 M
What is ProMIS Neurosciences quarterly accounts payable year-on-year change?
Over the past year, PMN quarterly accounts payable has changed by -$6.84 M (-81.28%)